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Abstract
Introduction: The standard treatment for obstructive sleep apnoea syndrome is nasal
continuous positive airway pressure. In most cases the obstruction is located at the oropharyngeal
level, and nasal continuous positive airway pressure is usually effective. In cases of non-response to
nasal continuous positive airway pressure other treatments like mandibular advancement devices
or upper airway surgery (especially bi-maxillary advancement) may also be considered.
Case presentation: We report the case of a 38-year-old Caucasian man with severe obstructive
sleep apnoea syndrome, initially refractory to nasal continuous positive airway pressure (and
subsequently also to a mandibular advancement devices), in which the visualization of the upper
airway with sleep endoscopy and the concomitant titration of positive pressure were useful in the
investigation and resolution of sleep disordered breathing. In fact, there was a marked reduction in
the size of his nasopharynx, and a paresis of his left aryepiglotic fold with hypertrophy of the right
aryepiglotic fold. The application of bi-level positive airway pressure and an oral interface
successfully managed his obstructive sleep apnoea.
Conclusion: This is a rare case of obstructive sleep apnoea syndrome refractory to treatment
with nocturnal ventilatory support. Visualization of the endoscopic changes, during sleep and under
positive pressure, was of great value to understanding the mechanisms of refractoriness. It also
oriented the therapeutic option. Refractoriness to obstructive sleep apnoea therapy with
continuous positive airway pressure is rare, and each case should be approached individually.
Introduction
Obstructive sleep apnoea syndrome (OSAS) is characterized
byarecurrentcollapseofallorsomepartsoftheupperairway
during sleep. Despite being sub-diagnosed, it affects 2% to
4% of the world’s population [1] and has a higher prevalence
in obese people [2]. This syndrome is associated with
increased cardiovascular risk. It is also an independent risk
factor for hypertension, myocardial infarction and stroke [3].
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respiratory study is simple and easy to use on an
outpatient basis.
Nasal continuous positive airway pressure (nCPAP)
during sleep, which allows airway patency, is the current
standard treatment [4]. It significantly improves patients’
excessive daytime sleepiness, states of wakefulness,
cognitive abilities [5], and quality of life [6]. This
treatment also decreases cardiovascular risk, especially
when it is used for more than 4 hours daily [7].
Alternative treatments include a mandibular advance-
ment device (MAD) that increases the lumen of the
airway by inducing jaw and tongue protrusion during
sleep, improves the tone of the muscles of the airway,
and reduces the passive compliance of the pharyngeal
wall [8]. It is especially effective in non-obese patients
with moderate OSAS.
Upper airway surgery, specifically bi-maxillary surgery, is
also effective in severe cases of OSAS. It may be
considered for patients who are unwilling to use, or are
refractory to, nCPAP therapy and whose anatomical
changes are prone to surgical resolution [9]. This
approach must be made and addressed specifically.
Case presentation
We report a 38-year-old Caucasian man who was referred
toour department for suspectedOSAS with complaintsof
severe snoring, respiratory pauses that were witnessed by
his wife, morning headaches, and adynamia, but without
acknowledgement of excessive daytime sleepiness.
He had a history of dyslipidemia treated with diet and
statin, without the existence of other cardiovascular risk
factors. He had low alcohol consumption (10 gr/day)
and no history of smoking. A physical exam revealed
macroglossia, a bulky soft palate and uvula. He was
o v e r w e i g h tw i t hab o d ym a s si n d e x( B M I )o f2 9 . 1a n d
had a cervical perimeter of 42 cm. As an initial diagnostic
approach, a spirometry and chest X-ray were performed,
which revealed no changes. A diagnostic cardiorespira-
tory study showed that in addition to extended periods
of snoring, he also had severe OSAS with an apnoea and
hypopnoea index (AHI) of 72.1/h, a desaturation index
of 67.1/h, and a minimum O2 saturation of 69%.
With the diagnosis of severe OSAS, despite the lack of
excessive daytime sleepiness, a trial of positive airway
pressure (automatic mode) was proposed, with the
minimal pressure of 4 cmH20 and maximum pressure
of 15 cmH2O. General measures of sleep hygiene and
weight reduction were also recommended. As an
alternative, the use of MAD was considered, and the
patient was referred to our hospital’s orthodontics
department.
The patient was evaluated after 3 months and there was
no adherence to treatment, with only 3 minutes of use
per night, with a total number of 6 days of use. The
patient attributed this to his difficulty in adapting to the
masks and to the pressure itself.
MAD (Figure 1) was applied over the next 3 months.
During this period, our patient used the device daily for
3 to 4 hours per night, as limited by some salivation and
gum pain. His clinical symptoms, however, did not
improve.
For a better evaluation of our patient’s clinical response,
we did a home cardiorespiratory study using MAD
(Figure 2), which showed no significant improvement in
his OSAS. (He had an AHI of 61.4/h and desaturation
index of 42.1/h with MAD during the first 3.5 hours of
recording).
To titrate CPAP pressures and to better characterize our
patient’s sleep structure, we conducted a split-night
polysomnography. The first part of the night confirmed
the severity of our patient’sO S A( A H Io f6 4 . 9 / hw i t h
minimum O2 saturation of 29%). The second part
allowed a gradual increase of positive pressure, first in
continuous mode (CPAP) for up to 16 cmH2O, then in
the bilevel mode (BiPAP) with a maximum inspiratory
pressure (IPAP) of 24 cmH2O and a maximum
expiratory pressure (EPAP) of 20 cmH2O. Persistent
obstructive events with marked desaturation, with a
minimum O2 saturation of 45% in CPAP mode and of
82% in BiPAP mode (Figure 3) were prevalent.
Figure 1
An example of a mandibular advancement device.
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of pressures was conducted during the day to confirm
this refractoriness and optimize the interface. At that
moment the patient was prescribed bilevel-positive air
pressure (VIVO 30, Breas) with 20 cmH2O of IPAP and
12 cmH2O of EPAP and a gel face mask (Mojo).
After a period with these settings, the patient’s symptoms
remained, but he developed a newly diagnosed hyper-
tension, which was treated with antihypertensive med-
ication. Home nocturnal oximetry (in bilevel mode with
those parameters) maintained episodes of desaturation,
suggesting a large number of residual apnoea and/or
hypopnoea events (Figure 4).
His refractoriness led to further investigations which
were done using two methods of evaluation. In the first
one, a facial computed tomography (CT) revealed a
smaller upper airway (Figure 5). Reformatting (Figure 6)
showed an angular dysmorphia at the hypopharynx [10].
T h es e c o n dm e t h o du s e ds l e e pn a s o e n d o s c o p y( F i g u r e
7) with concomitant polysomnography and titration of
ventilatory support pressures (Figure 8) [6]. In this
evaluation, the patient was able to sleep effectively, and
a marked reduction of the size of the nasopharynx and a
paresis of the left aryepiglotic fold with hypertrophy of
the right one (Figure 7A) were noted. Extended periods
of vibration of the walls of the oropharynx related to
snores were also observed. With the establishment of
positive pressure ventilation, a subocclusion of the
nasopharynx persisted (up to IPAP/EPAP levels of 24/
16 cmH2O). An unrolling of the epiglottis that collapsed
the airway and provoked periods of O2 desaturation
(Figure 7C) was noted a few times. These episodes
improved under 20 cmH20 IPAP and 13 cmH20 EPAP
with an Oracle® mask. A home oximetry under a bilevel
mode with these pressures and interface (Figure 9)
revealed a significant improvement in our patient’s
nocturnal desaturation episodes.
Discussion
Refractoriness of OSAS therapy is rare and its approach
s h o u l db et a r g e t e dt os p e c i f i ci n d i v i d u a l s .
The conventional method for administering CPAP is
using a nasal or oronasal interface [11] based on
Figure 2
A cardiorespiratory study in the use of a mandibular advancement device. An evaluation at 4 months with a
cardiorespiratory study in the use of a mandibular advancement device (first 3.5 h of study) showed no significant
improvement in the patient's obstructive sleep apnoea syndrome (apnoea and hypopnoea index at 61.4/h and desaturation
index of 42.1/h). A severe condition of obstructive sleep apnoea syndrome was observed with and without the use of the
device.
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Split-night polysomnography: Obstructive sleep apnoea syndrome refractoriness with continuous positive
airway pressure and bilevel positive airway pressure, nasal mask. (Evaluation at 4 months). The first part of the night
confirmed the severity of obstructive sleep apnoea syndrome (apnoea and hypopnoea index of 64.9/h with minimum O2
saturation of 29%). The second part allowed a gradual increase in positive pressure, first in continuous positive airway pressure
for up to 16 cmH2O, then in bilevel positive airway pressure with a maximum inspiratory pressure of 24 cmH2O and a
maximum expiratory pressure of 20 cmH2O. There were persistent obstructive events with marked desaturation (minimum
O2 saturation of 45% in continuous mode and of 82% in bilevel mode).
Figure 4
A home nocturnal oximetry (in bilevel mode) with nasal mask. (Evaluation at 5 months). A home nocturnal oximetry
(in bilevel mode, inspiratory pressure of 20 cmH2O and expiratory pressure of 12 cmH2O, and a gel face mask (Mojo) shows
episodes of desaturation suggesting a large number of residual apnoea and/or hypopnoea events.
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oropharynx collapse (PCrit) [12]. Patients’ compliance
to treatment is somewhat constrained by the side effects
associated with the use of these interfaces, such as nasal
congestion, dryness of the oronasal mucosa, epistaxis,
and claustrophobia. The oral route is an alternative that
c a nb eu s e di nc a s e sw h e r et h ep a t i e n ti si n t o l e r a n tt o
conventional approaches [13].
According to recent literature [14], the air acts as a
resistor to the physiological nasal obstruction which
produces collapsing forces that manifest at the most
collapsible point, the pharynx. Positive pressure applied
through the nose has to overcome the PCrit that results
from the composition of pressure at the point of collapse
of the airway and the surrounding soft tissue. Because
the soft palate is complacent, the PCrit to be overcome is
similar to the positive pressure that is applied through
the mouth. The Oracle mask (Fisher and Paykel) has
shown to be effective in the treatment of OSAS [13], as it
applies a pressure-flow relationship to the oropharynx
Figure 5
A facial computed tomography at 5.5 months
following the initial presentation shows a smaller
upper airway.
Figure 6
A facial computed tomography reformation at 5.5
months after the initial presentation shows an
angular dysmorphia at the hypopharynx level.
Figure 7
(A) Sleep endoscopy before ventilation. Extended
periods of vibration of the walls of the oropharynx related to
snores were observed. With the establishment of positive
pressure ventilation, the nasopharynx subocclusion persisted
up to 24 cmH2O inspiratory pressure and 16 cmH2O
expiratory pressure. An unrolling of the epiglottis that
collapsed the airway and provoked periods of O2
desaturation was also noted. (C) Sleep nasoendoscopy
under continuous positive airway pressure with P > 16
cmH2O at 6 months after the initial presentation. In this
evaluation, a marked reduction of the size of the
nasopharynx, and a paresis of the left aryepiglotic fold with
hypertrophy of the right one were noted.
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changes in the superior airway [15]. It also has the
advantage of fewer side effects.
In this particular case, the visualization, during sleep and
under positive pressure, of the endoscopic changes, was
of great value to the understanding of the mechanisms of
refractoriness.
The application of a positive pressure in an airway with
anatomical changes (such as occurred in the case
described) could perhaps have caused valve mechanisms
Figure 8
A polysomnography study during sleep endoscopy at 6 months after the initial presentation. A polysomnography
and titration of ventilatory support pressures were also performed during sleep endoscopy.
Figure 9
A nocturnal oximetry under inspiratory pressure of 20 cmH20, expiratory pressure of 13 cmH20 with Oracle®
at 6.5 months after the initial presentation. A home oximetry under bilevel mode, inspiratory pressure of 20 cmH20 and
expiratory pressure of 13 cmH20 and Oracle® mask revealed a significant improvement in nocturnal desaturation episodes.
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consequent obstruction to the passage of air. This
phenomenon has become more evident with pressure
levels greater than 16 cmH2O. At the same time, with
lower pressures, the patency of the airway was not
established.
Based on these findings, the clinical decision to admin-
ister bilevel positive pressure during sleep through an
oral mask, which is not usually used in patients with
OSAS, overcame the major collapse of our patient’s
nasopharynx.
Conclusion
We describe a rare case of OSAS with refractoriness to
treatment with nocturnal ventilatory support and
emphasize the importance of endoscopic visualization
of the upper airway during sleep in order to clarify the
origin of refractoriness and concomitantly orient the
treatment.
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